Timber Pharmaceuticals (TMBR) Financials

$0.00

$0.00 (0.00%)

As on 31-Jan-2024 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

6.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.08	0.08	0.30	0.45	0.32	0.06
Cost of Revenue	8.73	13.30	6.15	1.50	3.38	0.08
Gross Profit	-8.65	-13.22	0.30	-1.05	-3.06	-0.03
Operating Expenses	14.54	19.24	10.95	18.71	0.59	16.48
Operating Profit (EBIT)	-14.69	-19.24	-10.65	-20.21	-3.64	-17.23
Other Income	--	--	--	5.13	--	--
Profit before Tax	-14.93	-19.37	-10.67	-15.08	-3.64	-17.26
Provision for Tax	0.19	0.01	-0.03	0.04	0.00	0.00
Profit after Tax (Net Income)	-15.05	-19.38	-10.64	-15.12	-3.69	-17.26
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-3.19	--	-10.77	-15.26	-3.69	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-2.62	5.23	13.27	7.61	-1.38	1.30
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.32	1.68	0.44	2.64	0.50	0.06
Current Liabilities	5.62	5.04	4.19	1.38	1.47	2.30
Total Liabilities	8.95	10.28	17.90	11.63	0.09	3.65

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.54	0.46	0.78	0.90	1.14	0.27
Current Assets	2.79	9.81	17.12	10.73	0.09	3.39
Total Assets	8.95	10.28	17.90	11.63	0.09	3.65
Total Debt*	0.55	0.33	0.70	0.83	0.18	--
Net Current Assets	-2.83	4.77	12.93	9.34	-1.38	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-15.85	-9.31	-8.29	-1.23	-14.99
Cash Flow from Investing Activities	--	--	-0.02	-2.66	-0.38	--
Cash from Financing Activities	--	8.13	15.79	21.24	1.68	10.53
Net Cash Inflow / Outflow	--	--	--	10.29	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-198.42	-94.94	-417.34	-7,396.40	-541.85
ROE (%)	--	-209.49	-101.93	-485.18	9,435.52	-541.85
ROA (%)	-118.33	-137.55	-72.06	-258.03	-197.13	-293.90
EBIT Margin (%)	-17,458.31	-23,125.86	-3,601.23	-4,453.82	-1,136.66	-30,224.56
Net Margin (%)	-18,090.74	-23,299.05	-3,597.49	-270.64	-1,136.66	-30,277.19
Cash Profit Margin (%)	-0.05	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-88.38	-0.72	-0.35	0.40	4.70	-0.22
EBIT Growth (%)	20.87	-80.61	47.31	-447.73	78.58	28.02
Net Profit Growth (%)	18.30	-82.15	29.62	-309.68	78.62	-92.23
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	6.94	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.13	0.46	1.55	0.54	-2.65	0.18
Close Price ($)	2.43	1.75	19.00	37.15	254.40	1,618.50
High Price ($)	16.00	20.53	182.50	630.00	2,677.50	5,626.50
Low Price ($)	1.20	1.20	17.90	33.26	154.80	750.00
Market Cap ($ Cr)	1.18	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.06	0.05	0.11	-0.13	--
Short term debt to equity ratio	-0.08	0.06	0.03	0.03	-0.13	--
Current Ratio	0.50	1.95	4.08	7.76	0.06	1.47
Quick Ratio	0.50	--	--	--	--	--
Interest Coverage	-56.37	-84.20	-684.86	-4.58	--	-615.29

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	1.23	7.02
Asset Turnover	0.01	0.01	0.02	0.08	0.17	0.01
Receivable days	--	--	--	3.22	4.50	35.24
Inventory Days	--	--	--	--	--	44.01
Payable days	--	31.63	40.04	109.07	100.66	6,026.63
Cash Conversion Cycle	--	--	--	--	--	-5,947.38

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.